TK inhibitor treatment disrupts growth hormone axis: clinical observations in children with CML and experimental data from a juvenile animal model.

TK inhibitor treatment disrupts growth hormone axis: clinical observations in children with CML and experimental data from a juvenile animal model.

Item
http://www.wikidata.org/entity/Q30635067
Impact of long-term exposure to the tyrosine kinase inhibitor imatinib on the skeleton of growing ratsPediatric chronic myeloid leukemia is a unique disease that requires a different approachIndications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.Recognizing Endocrinopathies Associated With Tyrosine Kinase Inhibitor Therapy in Children With Chronic Myelogenous Leukemia.Multiparameter Analysis of Off-Target Effects of Dasatinib on Bone Homeostasis in Patients With Newly Diagnosed Chronic Myelogenous Leukemia.Chronic Myelogenous Leukemia- Initiating Cells Require Polycomb Group Protein EZH2.The complexity of growth failure in children receiving tyrosine kinase inhibitor therapy for chronic myelogenous leukemia.Pharmacology and pharmacokinetics of imatinib in pediatric patients.Adverse effects of imatinib in children with chronic myelogenous leukemia.Sustained complete molecular remission after imatinib discontinuation in children with chronic myeloid leukemia.
P2860

TK inhibitor treatment disrupts growth hormone axis: clinical observations in children with CML and experimental data from a juvenile animal model.

Item
http://www.wikidata.org/entity/Q30635067
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
TK inhibitor treatment disrupt ...... from a juvenile animal model.
@ast
TK inhibitor treatment disrupt ...... from a juvenile animal model.
@en
type
label
TK inhibitor treatment disrupt ...... from a juvenile animal model.
@ast
TK inhibitor treatment disrupt ...... from a juvenile animal model.
@en
prefLabel
TK inhibitor treatment disrupt ...... from a juvenile animal model.
@ast
TK inhibitor treatment disrupt ...... from a juvenile animal model.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
TK inhibitor treatment disrupt ...... from a juvenile animal model.
@en
P2093
P304
P31
P356
P433
P478
P577
P698